Advertisement

Topics

HELSINN HEALTHCARE S.A. Company Profile

14:01 EDT 25th June 2018 | BioPortfolio

Helsinn's strategy is focused on three activities Integrated Licensing Helsinn uses an innovative approach to develop and market new pharmaceutical products:
INTEGRATED LICENSING
Helsinn adds scientific and market value to its products.
Integrated Manufacturing Helsinn is a qualified developer and producer of Active Pharmaceutical Ingredients (APIs), High Potency Active Ingredients (HPAIs) and finished dosage forms.
Helsinn delivers a ready-to-market product to its partners.
Pharmaceutical Business
Helsinn is engaged in local sales and marketing in the Irish market with two sales teams.

Location

via Pian Scairolo 9
Pazzallo
6912
Switzerland

Contact

Phone: 41 91 985.21.21
Fax: 41 91 993.21.22


News Articles [594 Associated News Articles listed on BioPortfolio]

Helsinn and Eisai take Aloxi patent fight all the way to US Supreme Court

After a US appeals court last year ruled against Helsinn Healthcare in its patent dispute with Israel’s…

BRIEF—Helsinn Therapeutics appoints new chief executive

Switzerland’s Helsinn Group has appointed Paul Rittman as chief executive of its US subsidiary Helsinn…

Helsinn obtains orphan designation for pracinostat to treat AML

Swiss pharmaceutical group Helsinn and US-based oncology firm MEI Pharma have obtained orphan drug designation from the European Medicines Agency...Read More... The post Helsinn obtains orphan designa...

Helsinn: Second Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Rajiv Agarwal, MD, Memorial Sloan Kettering Cancer Center

Second Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Rajiv Agarwal, MD, Memorial Sloan Kettering Cancer Cen...

New formulation of Helsinn's Akynzeo OK'd by FDA

The FDA approved Helsinn's intravenous formulation of Akynzeo, or fosnetupitant and palonosetron, in combination with dexamet -More- 

Helsinn and the Scientific Centre of Monaco collaborate

Helsinn International Services and the Scientific Centre of Monaco (CSM), signed a collaboration agreement to support a research project aimed at developing pharmacological inhibitors for the most com...

Press Release: Helsinn Group and MEI Pharma -2-

Press Release: Helsinn Group and MEI Pharma Announce Upcoming Presentation at ASCO 2018 on the design of the Phase III PRIMULA study of Pracinostat in combination with azacitidine for the treatmen...

Appointments: Changes at SOTIO, Helsinn, Sobi, AMRI, Blade and Vertex

The latest biopharma industry appointments include a new chairman at Bone Therapeutics, chief executives at SOTIO and Helsinn Therapeutics, new...   

Drugs and Medications [446 Associated Drugs and Medications listed on BioPortfolio]

Bacti-stat [Ecolab Inc.]

Drug Facts

Oxygen [Mon HealthCare]

oxygen

Isagel [Coloplast Manufacturing US, LLC]

Isagel HandwashingNo-Rinse, Antiseptic Hand Cleansing Gel with Added Moisturizers

Endure 200 [Ecolab Inc.]

Drug Facts

Tiger balm [Haw Par Healthcare Ltd.]

TIGER BALM PAIN RELIEVING LARGE PATCH

PubMed Articles [1007 Associated PubMed Articles listed on BioPortfolio]

The Second Society for Simulation in Healthcare Research Summit: Beyond our Boundaries.

In this article, we report on the Second Society for Simulation in Healthcare Research Summit held in 2017. This meeting succeeded the First Research Summit from 2011 with the goal of advancing the sc...

A Future-Focused Approach to Behavioral Healthcare.

Interview With Rulon F. Stacey, PhD, FACHE, Managing Director, Healthcare, Navigant Consulting.

Practitioner Application: Ten CEO Imperatives for Healthcare Transformation: Lessons From Top-Performing Academic Medical Centers.

Healthcare use for children with complex needs: using routine health data linked to a multiethnic, ongoing birth cohort.

Congenital anomaly (CA) are a leading cause of disease, death and disability for children throughout the world. Many have complex and varying healthcare needs which are not well understood. Our aim wa...

Clinical Trials [994 Associated Clinical Trials listed on BioPortfolio]

My Life, My Healthcare

This study is designed to answer the following questions: "Is the My Life, My Healthcare Discussion Aid feasible for use in primary care? Does it positively impact patient and healthcare t...

Asymptomatic Flu Project

Although clinical presentation of influenza is often symptomatic, asymptomatic cases also occur. The knowledge of the incidence of asymptomatic influenza among healthcare workers is very i...

Ubiquitous Healthcare Service With Multifactorial Intervention in Diabetes Care

Recently, we generated a new multidisciplinary ubiquitous healthcare system by upgrading our clinical decision supporting system (CDSS) rule engine, and integrating a physical activity-mon...

Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel

The purpose of the study on the Prevention of Influenza and Other Wintertime Respiratory Viruses among Healthcare Professionals in Israel Effectiveness of Influenza Vaccine in Preventing I...

Implementation of Medical Weight Management by Telemedicine

As the prevalence and associated healthcare costs of obesity continue to increase, the need for obesity treatments that contribute to weight loss maintenance are needed. Through the functi...

Companies [1791 Associated Companies listed on BioPortfolio]

HELSINN HEALTHCARE S.A.

Helsinn's strategy is focused on three activities Integrated Licensing Helsinn uses an innovative approach to develop and market new pharmaceutical products:INTEGRATED LICENSINGHelsinn adds scient...

Helsinn Healthcare SA

Helsinn is a privately owned pharmaceutical group with headquarters in Lugano, Switzerland, and subsidiaries in USA and Ireland. Helsinn's unique business model is focused on the licensing of phar...

Helsinn Group and DARA BioSciences, Inc.

Helsinn is a privately owned pharmaceutical group with headquarters in Lugano, Switzerland, and operating subsidiaries in Ireland and the United States. Helsinn’s business mo...

Zelis Healthcare

Zelis Healthcare is a healthcare information technology company and market-leading provider of end-to-end healthcare claims cost management and payments solutions including networ...

Zelis™ Healthcare

Zelis Healthcare is a healthcare information technology company and market-leading provider of end-to-end healthcare claims cost management and payments solutions including networ...

More Information about "HELSINN HEALTHCARE S.A." on BioPortfolio

We have published hundreds of HELSINN HEALTHCARE S.A. news stories on BioPortfolio along with dozens of HELSINN HEALTHCARE S.A. Clinical Trials and PubMed Articles about HELSINN HEALTHCARE S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HELSINN HEALTHCARE S.A. Companies in our database. You can also find out about relevant HELSINN HEALTHCARE S.A. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record